Abiomed, Inc.ABMDNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P3
Near historical low
vs 5Y Ago
-4.2x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2022 | -80.29% |
| Q2 2022 | -13.76% |
| Q1 2022 | -12.73% |
| Q4 2021 | 49.39% |
| Q3 2021 | 9.42% |
| Q2 2021 | -35.98% |
| Q1 2021 | 9.28% |
| Q4 2020 | 2.49% |
| Q3 2020 | 143.11% |
| Q2 2020 | -63.32% |
| Q1 2020 | -3.18% |
| Q4 2019 | 20.44% |
| Q3 2019 | 14.90% |
| Q2 2019 | -8.19% |
| Q1 2019 | -5.66% |
| Q4 2018 | 23.21% |
| Q3 2018 | 29.87% |
| Q2 2018 | -17.32% |
| Q1 2018 | -0.52% |
| Q4 2017 | 31.37% |
| Q3 2017 | 18.91% |
| Q2 2017 | -2.58% |
| Q1 2017 | 9.17% |
| Q4 2016 | 96.62% |
| Q3 2016 | -34.21% |
| Q2 2016 | 16.95% |
| Q1 2016 | -11.13% |
| Q4 2015 | 41.47% |
| Q3 2015 | 64.39% |
| Q2 2015 | -40.24% |
| Q1 2015 | 20.75% |
| Q4 2014 | 125.34% |
| Q3 2014 | 110.41% |
| Q2 2014 | -67.76% |
| Q1 2014 | 17.11% |
| Q4 2013 | 63.90% |
| Q3 2013 | 15721.21% |
| Q2 2013 | -100.44% |
| Q1 2013 | -1.96% |
| Q4 2012 | 13.13% |